|
Market Closed -
Oslo Bors
10:45:00 2026-11-06 am EST
|
5-day change | 1st Jan Change | ||
| 0.5200 NOK | +1.96% |
|
-6.81% | -87.91% |
| Oct. 13 | Induct AS Expands Scope of Existing Severe Asthma Care Pathway | CI |
| Aug. 13 | Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Evolution of the Average Target: Induct
Evolution of the Target Price: Induct
Changes in Analyst Recommendations: Induct
05300784c6ad0b441382.U8XNdSxkpi0Ypi_5gCWDxaf5PH7-IPIYc5HJpmbJmMs.FaOKHUU90UR3kG6d9WnareS8dzmIY55rEeKx0lWWr4o1laAHShzqfn_jZg~624b7344c4284b08a5d077fd31f26c9c
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +96.08% | |||
| +18.14% | |||||
| +40.63% | |||||
| +104.46% | |||||
| +10.75% | |||||
| +26.65% | |||||
| +14.39% | |||||
| +25.93% | |||||
| +51.12% | |||||
| +8.87% | |||||
| Average | +39.70% | |||||
| Weighted average by Cap. | +25.43% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5200NOK
Average target price
1.000NOK
Spread / Average Target
+92.31%
High Price Target
1.000NOK
Spread / Highest target
+92.31%
Low Price Target
1.000NOK
Spread / Lowest Target
+92.31%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- INDCT Stock
- Consensus Induct
Select your edition
All financial news and data tailored to specific country editions
